Sleep deprivation – typically administered in controlled, inpatient settings – rapidly reduces symptoms of depression in roughly half of depression patients, according the first meta-analysis on the subject in nearly 30 years, from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Partial sleep deprivation (sleep for three to four hours followed by forced wakefulness for 20-21 hours) was equally as effective as total sleep deprivation (being deprived of sleep for 36 hours), and medication did not appear to significantly influence these results. The results are published today in the Journal of Clinical Psychiatry.
Although total sleep deprivation or partial sleep deprivation can produce clinical improvement in depression symptoms within 24 hours, antidepressants are the most common treatment for depression. Such drugs typically take weeks or longer to experience results, yet 16.7 percent of 242 million U.S. adults filled one or more prescriptions for psychiatric drugs in 2013. The findings of this meta-analysis hope to provide relief for the estimated 16.1 million adults who experienced a major depressive episode in 2014.
Previous studies have shown rapid antidepressant effects from sleep deprivation for roughly 40-60 percent of individuals, yet this response rate has not been analyzed to obtain a more precise percentage since 1990 despite more than 75 studies since then on the subject.
“More than 30 years since the discovery of the antidepressant effects of sleep deprivation, we still do not have an effective grasp on precisely how effective the treatment is and how to achieve the best clinical results,” said study senior author Philip Gehrman, PhD, an associate professor of Psychiatry and member of the Penn Sleep Center, who also treats patients at the Cpl. Michael J. Crescenz VA Medical Center. “Our analysis precisely reports how effective sleep deprivation is and in which populations it should be administered.”
Reviewing more than 2,000 studies, the team pulled data from a final group of 66 studies executed over a 36 year period to determine how response may be affected by the type and timing of sleep deprivation performed (total vs early or late partial sleep deprivation), the clinical sample (having depressive or manic episodes, or a combination of both), medication status, and age and gender of the sample. They also explored how response to sleep deprivation may differ across studies according to how “response” is defined in each study.
“These studies in our analysis show that sleep deprivation is effective for many populations,” said lead author Elaine Boland, PhD, a clinical associate and research psychologist at the Cpl. Michael J. Crescenz VA Medical Center. “Regardless of how the response was quantified, how the sleep deprivation was delivered, or the type of depression the subject was experiencing, we found a nearly equivalent response rate.”
Learn more: Sleep Deprivation is an Effective Anti-depressant for Nearly Half of Depressed Patients
The Latest on: Depression
[google_news title=”” keyword=”depression” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Dear Annie: Is It Depression or Something Else?on May 8, 2024 at 11:53 pm
I am a 48-year-old male living at home with my folks and older sister. We are a close-knit family and do things together often. I couldn't be happier to have them in my life.
- Marlon Wayans Speaks Honestly about His Depressionon May 8, 2024 at 2:00 pm
Whether you know it or not, May is Mental Health Awareness Month and in a new interview actor and comedian Marlon Wayans is opening up about his struggles.
- New guidelines for depression care emphasize patient-centered approach in Canadaon May 8, 2024 at 1:33 pm
Psychiatrists and mental health professionals have a new standard for managing major depression, thanks to refreshed clinical guidelines published today by the Canadian Network for Mood and Anxiety ...
- Ketamine Noninferior to ECT for Outpatients With Major Depressionon May 8, 2024 at 12:44 pm
NEW YORK CITY -- Treatment with ketamine was noninferior to electroconvulsive therapy (ECT) for major depressive disorder, two meta-analyses showed, though it was inferior for patients hospitalized ...
- Psychedelic Toad Venom Shows Promise for New Depression Treatmenton May 8, 2024 at 12:00 pm
Scientists have mapped the structure of a psychedelic drug derived from the Colorado River toad, which seems to have antidepressant effects.
- Serotonergic neuron findings suggest possible treatment for depression-related infertilityon May 8, 2024 at 11:12 am
Their findings also provide an explanation and possible treatment for the decreased fertility observed in people with depression. The results were published in Scientific Reports. People who lack ...
- New device that emits magnetic field may offer hope for treating depressionon May 8, 2024 at 9:38 am
A head-mounted device that generates an ultra-low frequency ultra-low magnetic field has been found to improve the symptoms of four male patients diagnosed with major depressive disorder. Future ...
- Psychedelic Toad Venom Could Be Used To Treat Depression Based On New Evidenceon May 8, 2024 at 9:36 am
Modern science has dreamed up a wide variety of treatments for depression, anxiety, and other mental issues, and researchers may have stumbled across a ...
- Psychedelic toxins from toads could treat depression and anxietyon May 8, 2024 at 8:00 am
By Corryn WetzelA psychedelic compound secreted by a poisonous toad could help treat depression and anxiety, according to a study in mice.When frightened, Colorado river toads (Incilius alvarius) ...
- New guidelines for depression care emphasize patient-centred approachon May 7, 2024 at 5:00 pm
Psychiatrists and mental health professionals have a new standard for managing major depression, thanks to refreshed clinical guidelines. Psychiatrists and mental health professionals have a new ...
via Google News and Bing News